Prothrombin metabolism in healthy subjects and in two patients with congenital hypoprothrombinemia

No abstract is available for this paper.

• Publication year

  1975

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-94-010-1927-9_13
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• EFFECT OF DYDROGESTERONE (DUPHASTON) ON HAEMOSTASIS AND LIVER FUNCTION

  1973cited by this paper
• Metabolism and distribution of fibrinogen. II. Fibrinogen turnover in polycythaemia, thrombocytosis, haemophilia A, congenital afibrinogenaemia and during streptokinase therapy.

  1972cited by this paper
• Metabolism of iodine labeled plasminogen and prothrombin in cirrhosis of the liver

  1972cited by this paper
• Human prothrombin metabolism in normal man and in hypocoagulable subjects.

  1969cited by this paper
• The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

  1969cited by this paper
• Durée de vie chez l'homme de la prothrombine marquée par l'iode radioactif (131I)

  1968cited by this paper
• Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

  1966cited by this paper
• The purification of human prothrombin.

  1966cited by this paper
• DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS *

  1964cited by this paper
• A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test).

  1963cited by this paper
• The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

  1961cited by this paper
• The Kinetics of the Distribution and Breakdown of I131-Albumin in the Rabbit

  1959cited by this paper
• Efficient Trace-labelling of Proteins with Iodine

  1958cited by this paper
• The Stuart-Prower Factor Assay and its Clinical Significance

  1958cited by this paper
• The theory of tracer experiments with 131I-labelled plasma proteins.

  1957cited by this paper
• Vapor Lubrication of Graphite Sliding Contacts

  1956cited by this paper
• Behaviour of 14C- and 131I-labelled plasma proteins in the rat.

  1956cited by this paper
• Purification of Bovine and Human Fibrinogen.

  1956cited by this paper
• Une micro-méthode de l’immuno-électrophorèse

  1955cited by this paper
• Two-stage procedure for the quantitative determination of prothrombin concentration.

  1949cited by this paper

• Phänotypische Heilung eines Faktor-II-Mangels durch Lebertransplantation

  2002cites this paper
• Phänotypische Heilung eines Faktor-II-Mangels durch Lebertransplantation

  2002cites this paper
• Use of prothrombin complex concentrates for prophylaxis and treatment of bleeding episodes in patients with hereditary deficiency of prothrombin, factor VII, factor X, protein C protein S, or protein Z.

  1999cites this paper
• Quantitation of prothrombin activation products in human urine

  1984cites this paper
• Turnover of human histidine-rich glycoprotein in healthy subjects and during thrombolytic therapy.

  1981cites this paper
• Labeled factor IX kinetics in patients with hemophilia-B.

  1981cites this paper
• Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma.

  1979cites this paper
• Turnover of radiolabelled plasminogen and prothrombin in cirrhosis of the liver

  1978cites this paper
• Quantitation of thrombin‐antithrombin III complexes in human blood

  1977cites this paper
• Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration

  1977cites this paper